These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 28646947)

  • 21. Measles elimination: progress and challenges.
    Cutts FT; Henao-Restrepo A; Olivé JM
    Vaccine; 1999 Oct; 17 Suppl 3():S47-52. PubMed ID: 10559534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experience in global measles control, 1990-2001.
    Henao-Restrepo AM; Strebel P; John Hoekstra E; Birmingham M; Bilous J
    J Infect Dis; 2003 May; 187 Suppl 1():S15-21. PubMed ID: 12721887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global eradication of measles: Are we poised?
    Kulkarni RD; Ajantha GS; Kiran AR; Pravinchandra KR
    Indian J Med Microbiol; 2017; 35(1):10-16. PubMed ID: 28303812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measles eradication: recommendations from a meeting cosponsored by the World Health Organization, the Pan American Health Organization, and CDC.
    MMWR Recomm Rep; 1997 Jun; 46(RR-11):1-20. PubMed ID: 9213745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Counterpoint: should childhood vaccination against measles be a mandatory requirement for attending school? No.
    Schröder-Bäck P; Martakis K
    Chest; 2015 Oct; 148(4):854-856. PubMed ID: 26043312
    [No Abstract]   [Full Text] [Related]  

  • 26. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A correlation of measles specific antibodies and the number of plasmacytoid dendritic cells is observed after measles vaccination in 9 month old infants.
    García-León ML; Bonifaz LC; Espinosa-Torres B; Hernández-Pérez B; Cardiel-Marmolejo L; Santos-Preciado JI; Wong-Chew RM
    Hum Vaccin Immunother; 2015; 11(7):1762-9. PubMed ID: 26075901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measles IgA in the nasal washings of adult volunteers and children immunized intranasally with measles vaccine L-16.
    Liashenko VA; Krasnova VP; Youminova NV
    Hum Antibodies; 1999; 9(3):143-8. PubMed ID: 10690626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measles resurgence following a nationwide measles vaccination campaign in Nigeria, 2005-2008.
    Weldegebriel GG; Gasasira A; Harvey P; Masresha B; Goodson JL; Pate MA; Abanida E; Chevez A
    J Infect Dis; 2011 Jul; 204 Suppl 1():S226-31. PubMed ID: 21666165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Americas: paving the road toward global measles eradication.
    Castillo-Solorzano C C; Matus CR; Flannery B; Marsigli C; Tambini G; Andrus JK
    J Infect Dis; 2011 Jul; 204 Suppl 1():S270-8. PubMed ID: 21666172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The unfinished measles immunization agenda.
    Strebel P; Cochi S; Grabowsky M; Bilous J; Hersh BS; Okwo-Bele JM; Hoekstra E; Wright P; Katz S
    J Infect Dis; 2003 May; 187 Suppl 1():S1-7. PubMed ID: 12721885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility of global measles eradication after interruption of transmission in the Americas.
    de Quadros CA; Andrus JK; Danovaro-Holliday MC; Castillo-Solórzano C
    Expert Rev Vaccines; 2008 Apr; 7(3):355-62. PubMed ID: 18393605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beyond vertical and horizontal programs: a diagonal approach to building national immunization programs through measles elimination.
    Orenstein WA; Seib K
    Expert Rev Vaccines; 2016 Jul; 15(7):791-3. PubMed ID: 26967373
    [No Abstract]   [Full Text] [Related]  

  • 34. Measles elimination in the Americas: a comparison between countries with a one-dose and two-dose routine vaccination schedule.
    Sever AE; Rainey JJ; Zell ER; Hennessey K; Uzicanin A; Castillo-Solórzano C; Dietz V
    J Infect Dis; 2011 Sep; 204 Suppl 2():S748-55. PubMed ID: 21954277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progress toward measles elimination--region of the Americas, 2002-2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Apr; 53(14):304-6. PubMed ID: 15085074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measles.
    Moss WJ; Griffin DE
    Lancet; 2012 Jan; 379(9811):153-64. PubMed ID: 21855993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of a More Immunogenic Measles Vaccine by Increasing Its Hemagglutinin Expression.
    Julik E; Reyes-Del Valle J
    J Virol; 2016 Jun; 90(11):5270-5279. PubMed ID: 26984727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First 5 years of measles elimination in southern Africa: 1996-2000.
    Biellik R; Madema S; Taole A; Kutsulukuta A; Allies E; Eggers R; Ngcobo N; Nxumalo M; Shearley A; Mabuzane E; Kufa E; Okwo-Bele JM
    Lancet; 2002 May; 359(9317):1564-8. PubMed ID: 12047966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successes and failures in measles control.
    Cutts FT; Markowitz LE
    J Infect Dis; 1994 Nov; 170 Suppl 1():S32-41. PubMed ID: 7930752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Point: should childhood vaccination against measles be a mandatory requirement for attending school? Yes.
    Silverman RD; Hendrix KS
    Chest; 2015 Oct; 148(4):852-854. PubMed ID: 26043226
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.